IMUNON (IMNN) announced new safety and immunogenicity data from ongoing analyses of results from the Company’s first Phase 1 proof-of-concept ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...
The following is a summary of “Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection,” published in the February 2025 issue of BMC Infectious Diseases by ...
Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter ...
New research published in Cell found a bat-infecting coronavirus can enter human cells in a similar way to COVID-19. Dr Samuel Ellis, Research Fellow, Great Ormond Street Institute of Child Health ...
The World Health Organization has warned that its largest global laboratory network is on the brink of collapse unless new funding is secured to replace the support lost after President Donald Trump’s ...
Doctor of Biological Sciences, Russian professor-virologist Alexander Shestopalov commented on reports of a new coronavirus ...
Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now.
NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.
Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...
Hospitalisations and deaths attributed to COVID have dropped significantly since a peak in 2022. But a new variant could ...